Belimumab In Early Systemic Lupus Erythematosus
Condition(s):Lupus Erythematosus, SystemicLast Updated:July 8, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Lupus Erythematosus, SystemicLast Updated:July 8, 2022Completed
Condition(s):Kidney TransplantationLast Updated:January 9, 2023Terminated
Condition(s):Systemic Lupus ErythematosusLast Updated:June 9, 2022Unknown status
Condition(s):Systemic Sclerosis Associated Interstitial Lung Disease; Scleroderma, SystemicLast Updated:January 5, 2024Recruiting
Condition(s):NMO Spectrum DisorderLast Updated:March 10, 2023Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:December 7, 2017Unknown status
Condition(s):Graft Vs Host Disease; Graft-versus-host-diseaseLast Updated:March 13, 2024Completed
Condition(s):cGVHDLast Updated:January 18, 2023Withdrawn
Condition(s):Systemic Lupus ErythematosusLast Updated:September 21, 2023Not yet recruiting
Condition(s):Chronic Obstructive Pulmonary Disease; EmphysemaLast Updated:July 18, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.